Fritextsökning
Innehållstyper
-
Rapid developments in AI – “All stakeholders are struggling to understand it”
Artificial intelligence is being discussed more and more, and developments in the field are moving rapidly. As the Swedish Medical Products Agency testifies, ke...
-
Engage with your CMO early
Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.
-
Hello Angelica Loskog!
Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.
-
Study: Our behaviour may have been guided by wishful thinking during the pandemic
A new study suggests that we systematically underestimate health risks if and when it suits us. This was especially true during the pandemic, as our risk assess...
-
Amorphous materials take centre stage when Orexo develops new formulations
Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...
-
Neutronmöte i Lund samlar hundratals toppforskare
För första gången hålls en konferens knuten till den nya forskningsanläggningen ESS i Lund. Det är Institut Laue-langevin, ILL, i Frankrike och European Spallation Source, ESS, som tillsammans samlar neutronforskare från hela världen....
-
Lucy Robertshaw: There is a bio revolution happening right now
Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.
-
Studie: Klent stöd för nyttan av många nya cancerläkemedel
Nya cancerläkemedel lanseras i strid ström, men sker det för fort? Enligt en studie från Göteborgs universitet saknas det i många fall vetenskapligt stöd för at...
-
He got inside the head of Sweden’s vaccine hunter
The hunt for the COVID-19 vaccine is the theme of the new book Vaccinjägaren (The Vaccine Hunter). It tells the story of Richard Bergström’s mission as Sweden’s...
-
ALS – When the body has given up, but the brain persists
The nerve disease ALS gradually deprives the patient of control over the muscles and, eventually, also of speech. The eyes continue to function, though, and wit...
-
Lucy Robertshaw: Are we in the perfect storm?
“Is there a perfect storm on the horizon again as elective surgeries were cancelled due to patients being admitted with Covid-19? We now have a long backlog of ...
-
“We need to keep investing in research and innovation”
Jenni Nordborg has worked for just over four years to highlight life science in Sweden. Her mandate as national coordinator ends in December 2022. ““Life scienc...
-
Covid-19 ger allt snabbare insjuknande – omikron kortar inkubationstiden
Sedan virusvarianten omikron blev helt dominerade i spridningen av covid-19 har inkubationstiden sjunkit kraftigt, till bara drygt tre dygn, enligt en ny metastudie.
-
19 medicines in Sweden are under investigation in a major EMA inquiry
19 medicines marketed in Sweden are affected by an ongoing extensive European investigation into suspected fraud at an Indian contract research organisation. Am...
-
Uppsala-based company wins important patent dispute – but the decision is subject to appeal
A US district court has ruled in favour of Orexo in a dispute over the patent protecting the Swedish company’s drug Zubsolv, developed for treating patients wit...
-
Swedish-Danish meeting at Medicon Village: “One of the most important life science congresses”
For the eleventh year, The Future of Swedish and Danish Life Science was held on Wednesday, and the event continues to function as a connecting link between the...
-
Study: An objective diagnosis of constant tinnitus may be possible
A new method that measures brain activity during sound stimulation can make it possible to objectively diagnose and identify people who suffer from constant tin...
-
Vinnova finansierar innovation i spåren av corona
Sjuk verksamheter inom vårdsektorn tilldelas sju miljoner kronor för bland annat studier om covid-19-behandling med stamceller och framtagning av återanvändings...
-
Business Sweden’s new team is rolling out the blue-yellow carpet
According to Business Sweden’s life science team, the combination of substantial medical know-how and an ever-flourishing tech sector is a success factor for Sw...
-
New study: Post-Covid symptoms are common even after mild Covid-19
According to researchers at the University of Gothenburg, loss of smell and taste, shortness of breath and chest symptoms are the most common complaints after a...
-
New report: Fewer PhDs in life sciences
A new report from Vinnova suggests that competency returns in the life science sector are declining.
-
Swedish breakthrough in Alzheimer’s: “We can finally present great data”
Treatments for Alzheimer’s disease are currently among the hottest topics in drug development. Two Swedish research companies with high ambitions and successes ...
-
He is heading a new company for the development of Coegin’s cancer drug
The biotechnology company Coegin Pharma places the development of its drug candidate AVX420 in a newly formed company, Avexxin Oncology, based in Norway, and Jo...
-
Novavax is developing a vaccine candidate against Covid-19 and seasonal flu
A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...